Health
‘Harvard Thinking’: Who should take GLP-1s?
Samantha Laine Perfas
Harvard Staff Writer
October 21, 2026
long read
Experts dig into what we’ve overlooked in rush to embrace ‘magical’ weight-loss drugs
GLP-1s were created to treat Type 2 diabetes. But since their discovery as a tool for fighting obesity, they have surged in popularity. As of last year, nearly one in eight American adults were …